Morgan Stanley vs Stryker Corporation — how do they compare? Morgan Stanley trades at $216.64 (market cap $331.60B), while Stryker Corporation trades at $314.62 (market cap $122.35B). The key difference: Morgan Stanley is far larger — about 2.7× Stryker Corporation's market cap, and Morgan Stanley pays the higher dividend (2.18%). Which is the better fit depends on your goals.
| MS | SYK | |
|---|---|---|
Market Cap | $331.60B | $122.35B |
Sector | Financials | Technology |
52-Week High | $228.42 | $403.53 |
52-Week Low | $139.09 | $282.58 |
Dividend Yield | 2.18% | 1% |
Enterprise Value | — | $134.10B |
Signals from Pluang's Aura AI — not financial advice
Morgan Stanley (MS) trades at $215.48, down 1.33% on the day, with a bullish technical signal and strong fundamental performance. Revenue grew to $66.0B in 2025, with net income reaching $16.9B and a profit margin of 25.6%. The stock has beaten earnings estimates for three consecutive quarters, and analysts maintain a consensus buy rating with a $241.36 price target. Recent news highlights Morgan Stanley's role in leading Anthropic's IPO and expanding AI integration in wealth management.
The outlook for MS is positive, driven by earnings momentum and strategic initiatives like AI adoption and high-profile IPOs. Risks include volatile cash flows from operations and rising debt-to-asset ratios. The stock offers potential upside to the consensus target, but investors should monitor execution on growth initiatives and macroeconomic impacts on financial services.
No Aura AI signal available yet.
Trailing returns across standard periods
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.
Read more on MS →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →